Hormone blocking drugs may prolong the lives of men who's prostate cancer returns.
Most prostate cancer patients undergo radiation after a recurrence of the disease, but a new study found that the combination of drugs and radiation that block male hormones is most effective.
After 12 years, roughly 76-percent of men who got both treatments were still alive, compared to the 71-percent who only had radiation.
The hormone blocking treatment had the greatest benefits for men who had aggressive cancers.
